2022年11期
刊物介紹
期刊簡(jiǎn)介 《老年心臟病學(xué)雜志(英文版)》(Journal of Geriatric Cardiology, JGC)是由中國(guó)人民解放軍總醫(yī)院主管、解放軍總醫(yī)院老年心血管病研究所主辦、科學(xué)出版社第二主辦的國(guó)際性醫(yī)學(xué)學(xué)術(shù)期刊。該雜志創(chuàng)刊于2004年,國(guó)際標(biāo)準(zhǔn)刊號(hào)ISSN1671-5411,國(guó)內(nèi)統(tǒng)一刊號(hào)CN11-5329/R?!独夏晷呐K病學(xué)雜志(英文版)》致力于國(guó)際老年心臟病學(xué)交流,特別是將國(guó)內(nèi)老年心臟病學(xué)及相關(guān)領(lǐng)域的學(xué)術(shù)進(jìn)展介紹給國(guó)外同行。主要欄目有臨床研究、基礎(chǔ)研究、綜述、病例報(bào)告、專題論文集、讀者來(lái)信等。目前該刊已經(jīng)被SCIE、PubMed Central (PMC)、Scopus、EMBase、Chemical Abstract(CA)、DOAJ、Chinese Science Citation Database (CSCD)、WanFang Data、CAS-OAJ、Open J-Gate 及Google Scholar等國(guó)內(nèi)、國(guó)際重要文獻(xiàn)檢索系統(tǒng)收錄, 是中國(guó)大陸心血管領(lǐng)域第一本被SCI收錄的期刊。 特色與優(yōu)勢(shì) 快速評(píng)審:所有來(lái)稿均可在一個(gè)月內(nèi)得到審稿意見(jiàn),接受稿件可在三個(gè)月內(nèi)發(fā)表;評(píng)審專家陣容強(qiáng)大:我們有來(lái)自世界各地的360名心血管領(lǐng)域?qū)<覟槲覀儗徃?能保證每篇稿件的審稿質(zhì)量,即使您的文章經(jīng)評(píng)審后不能在本雜志上發(fā)表,詳盡的評(píng)審意見(jiàn)也會(huì)對(duì)您的研究起到非常好的促進(jìn)作用;文章可見(jiàn)度高:本刊目前被許多國(guó)際著名醫(yī)學(xué)數(shù)據(jù)庫(kù)收錄,比如SCIE、PubMed、Scopus、 EMBase等,保證了每篇發(fā)表文章的可見(jiàn)度。
Journal of Geriatric Cardiology
RESEARCH ARTICLE
- Screening for hypertension-mediated organ damage and aetiology: still of value after 65 years of age?
- Effectiveness of sacubitril-varsartan versus angiotensin converting enzyme inhibitors in patients hospitalized for acute heart failure: a retrospective cohort study of the RICA registry
- Systemic inflammatory markers in elderly patients undergoing transcatheter aortic valve replacement
- Cost-utility analysis of transcatheter aortic valve implantation versus surgery in severe aortic stenosis patients with intermediate surgical risk in Thailand
- The relationship between serum miR-21 levels and left atrium dilation in elderly patients with essential hypertension
- Validating the accuracy of a multifunctional smartwatch sphygmomanometer to monitor blood pressure
- Small-molecule 7,8-dihydroxyflavone counteracts compensated and decompensated cardiac hypertrophy via AMPK activation